GSK Can't Sink Avandia Prescription Coverage RICO Suits

By Andrew Scurria · October 24, 2013, 1:57 PM EDT

GlaxoSmithKline LLC failed Wednesday to escape a trio of racketeering class actions in Pennsylvania federal court alleging its concealment of heart risks associated with the diabetes drug Avandia conned health benefit...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

IN RE: AVANDIA MARKETING, SALES PRACTICES AND PRODUCTS LIABILITY LITIGATION

Case Number

2:07-md-01871

Court

Pennsylvania Eastern

Nature of Suit

P.I.: Personal Inj. Prod. Liability

Date Filed

October 18, 2007